| Product Code: ETC7551139 | Publication Date: Sep 2024 | Product Type: Market Research Report | ||
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India plasma protease C1-inhibitor treatment market import shipment experienced a negative CAGR from 2020 to 2024, showing a declining trend. However, the growth rate improved slightly between 2023 and 2024, indicating a potential stabilization in the market after a period of slowdown.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Plasma Protease C1-inhibitor Treatment Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 India Plasma Protease C1-inhibitor Treatment Market - Industry Life Cycle |
3.4 India Plasma Protease C1-inhibitor Treatment Market - Porter's Five Forces |
3.5 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume Share, By Dosage Type, 2021 & 2031F |
3.7 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Plasma Protease C1-inhibitor Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of hereditary angioedema (HAE) in India |
4.2.2 Growing awareness about plasma protease C1-inhibitor treatment |
4.2.3 Rising healthcare expenditure and improved access to advanced treatments in India |
4.3 Market Restraints |
4.3.1 High cost associated with plasma protease C1-inhibitor treatment |
4.3.2 Limited availability of specialized healthcare facilities for HAE treatment in India |
4.3.3 Stringent regulatory requirements for approval and distribution of plasma protease C1-inhibitor treatment in the Indian market |
5 India Plasma Protease C1-inhibitor Treatment Market Trends |
6 India Plasma Protease C1-inhibitor Treatment Market, By Types |
6.1 India Plasma Protease C1-inhibitor Treatment Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By C1-inhibitors, 2021- 2031F |
6.1.4 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By C1-esterase Inhibitor, 2021- 2031F |
6.1.5 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Kallikrein Inhibitor (Kalbitor), 2021- 2031F |
6.1.6 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist (Firazyr), 2021- 2031F |
6.2 India Plasma Protease C1-inhibitor Treatment Market, By Dosage Type |
6.2.1 Overview and Analysis |
6.2.2 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Liquid/Injectable, 2021- 2031F |
6.2.3 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Lyophilized, 2021- 2031F |
6.3 India Plasma Protease C1-inhibitor Treatment Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.3.3 India Plasma Protease C1-inhibitor Treatment Market Revenues & Volume, By Independent Pharmacies and Outlets, 2021- 2031F |
7 India Plasma Protease C1-inhibitor Treatment Market Import-Export Trade Statistics |
7.1 India Plasma Protease C1-inhibitor Treatment Market Export to Major Countries |
7.2 India Plasma Protease C1-inhibitor Treatment Market Imports from Major Countries |
8 India Plasma Protease C1-inhibitor Treatment Market Key Performance Indicators |
8.1 Patient enrollment in HAE treatment programs |
8.2 Number of healthcare providers trained in administering plasma protease C1-inhibitor treatment |
8.3 Rate of adoption of plasma protease C1-inhibitor treatment in India |
9 India Plasma Protease C1-inhibitor Treatment Market - Opportunity Assessment |
9.1 India Plasma Protease C1-inhibitor Treatment Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 India Plasma Protease C1-inhibitor Treatment Market Opportunity Assessment, By Dosage Type, 2021 & 2031F |
9.3 India Plasma Protease C1-inhibitor Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Plasma Protease C1-inhibitor Treatment Market - Competitive Landscape |
10.1 India Plasma Protease C1-inhibitor Treatment Market Revenue Share, By Companies, 2024 |
10.2 India Plasma Protease C1-inhibitor Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here